Company news
Onco-Innovations Ltd. news
Latest news releases, newest first. Pick a year for every news release, call and deck from that year.
Onco-Innovations Announces 90% of $0.60 Warrants Have Been Exercised
August 15, 2025
Onco-Innovations Advances Progress Towards First-in-Human Trial with Avance Clinical Start-Up Agreement
August 4, 2025
Onco-Innovations Appoints Dr. Dennis Hall to Scientific & Clinical Advisory Board
July 20, 2025
Onco-Innovations Signs Agreement with Redwood AI to Advance Discovery and Evaluation of Its PNKP Inhibitor Technology
July 11, 2025
Onco-Innovations Strengthens Clinical Leadership with Appointment of Dr. Islam Mohamed as Advisory Board Chair
July 10, 2025
Onco-Innovations Enters Agreement with Nucro-Technics for IND-Enabling Studies, Taking a Key Step Toward Human Trials
July 4, 2025
Onco-Innovations CEO Highlights Strategic Milestones and R&D Progress in Special Investors' Conference Call
July 2, 2025
Onco-Innovations Welcomes AstraZeneca's Interest in Founding Role in PROmAI - an Inka-led AI-Oncology Consortium
June 27, 2025
Onco-Innovations' CEO to Host Special Investors' Conference Call on Wednesday, July 2, 2025
June 25, 2025
Onco-Innovations Engages the University of Alberta and Cross Cancer Institute to Expand PNKP Inhibitor Research into Hard-to-Treat Cancers
June 13, 2025
Onco-Innovations' Inka Health to Launch Global AI-Oncology Consortium to Advance Predictive Cancer Research
June 5, 2025
Onco-Innovations Announces Start of Manufacturing of Preclinical Testing Material for Its PNKP Inhibitor Technology by Dalton Pharma
May 26, 2025
Onco-Innovations Extends Marketing Program
May 26, 2025
Onco-Innovations Celebrates Listing of Common Shares on Cboe Canada
May 16, 2025
Decks
- Investor Presentation (March 2025)
Investor deck · 22 slides · March 2025
- Investor Presentation (February 2025)
Investor deck · 21 slides · February 2025